{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:13:46Z","timestamp":1788383626864,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011680","name":"King Fahad Medical City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jiph.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T15:52:36Z","timestamp":1616514756000},"page":"726-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Severity of COVID-19 infection in ACEI\/ARB users in specialty hospitals: A retrospective cohort study"],"prefix":"10.1016","volume":"14","author":[{"given":"Ahmed A.","family":"Alrashed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noara K.","family":"Alhusseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1533-9667","authenticated-orcid":false,"given":"Syed Mohammed Basheeruddin","family":"Asdaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushira","family":"Enani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada M.","family":"Alkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Mohzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram M.","family":"Alghalbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Alfahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma S.","family":"Albujaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Ben-Akresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-1376","authenticated-orcid":false,"given":"Ahmad","family":"Alamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10224","key":"10.1016\/j.jiph.2021.03.004_bib0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2021.03.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2021.03.004_bib0015","series-title":"WHO coronavirus disease (COVID-19) dashboard","author":"W.H. Organization","year":"2020"},{"key":"10.1016\/j.jiph.2021.03.004_bib0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: Transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jiph.2021.03.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101711","article-title":"Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?","volume":"35","author":"Al-Tawfiq","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"18","key":"10.1016\/j.jiph.2021.03.004_bib0030","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2021.03.004_bib0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fmed.2020.00190","article-title":"Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China","volume":"7","author":"Li","year":"2020","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.jiph.2021.03.004_bib0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/oby.22842","article-title":"Obesity is associated with severe forms of COVID-19","volume":"28","author":"Caussy","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.jiph.2021.03.004_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"10229","key":"10.1016\/j.jiph.2021.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jiph.2021.03.004_bib0055","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.jiph.2021.03.004_bib0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"Esler","year":"2020","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.jiph.2021.03.004_bib0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiph.2021.03.004_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jiph.2021.03.004_bib0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ehjcvp\/pvaa064","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blocker","volume":"7","author":"Grover","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"10","key":"10.1016\/j.jiph.2021.03.004_bib0080","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/ajh\/hpaa096","article-title":"Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives","volume":"33","author":"Felice","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jiph.2021.03.004_bib0085","article-title":"Association between renin-angiotensin system inhibitors and COVID-19 complications","author":"Liabeuf","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jiph.2021.03.004_bib0090","unstructured":"H. Plecher, Saudi Arabia: Average age of the population from 1950 to 2050, Statista. https:\/\/www.statista.com\/statistics\/262482\/median-age-of-the-population-in-saudi-arabia\/ (accessed Sep. 01, 2020)."},{"issue":"3","key":"10.1016\/j.jiph.2021.03.004_bib0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/jfcm.JFCM_41_17","article-title":"Family medicine practice in Saudi Arabia: the current situation and proposed strategic directions plan 2020","volume":"24","author":"Al-Khaldi","year":"2017","journal-title":"J Family Commun Med"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jhh.2017.16","article-title":"The hypertension, diabetes and chronic kidney disease triangle in Arab countries","volume":"31","author":"Abraham","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.jiph.2021.03.004_bib0105","first-page":"V","article-title":"Burden of diabetes mellitus in Saudi Arabia","volume":"9","author":"Naeem","year":"2015","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"10.1016\/j.jiph.2021.03.004_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1573399812666160126142605","article-title":"Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions","volume":"13","author":"Alwin Robert","year":"2017","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"10.1016\/j.jiph.2021.03.004_bib0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3892\/br.2017.920","article-title":"Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion\/deletion gene polymorphisms in a Saudi Arabian population","volume":"7","author":"Al-Saikhan","year":"2017","journal-title":"Biomed Rep"},{"issue":"1\u20132","key":"10.1016\/j.jiph.2021.03.004_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2007.10.002","article-title":"Candidate gene polymorphisms and their association with hypertension in Malays","volume":"388","author":"Ghazali","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.jiph.2021.03.004_bib0125","first-page":"3","article-title":"Association of angiotensin-converting enzyme gene insertion\/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus","volume":"11","author":"Nikzamir","year":"2008","journal-title":"Arch Iran Med"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/emm.2003.71","article-title":"Angiotensin converting enzyme I\/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients","volume":"35","author":"Agachan","year":"2003","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.jiph.2021.03.004_bib0135","doi-asserted-by":"crossref","first-page":"e1977","DOI":"10.1002\/rmv.1977","article-title":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis","volume":"28","author":"Morra","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jiph.2021.03.004_bib0140","series-title":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance","author":"W.H. Organization","year":"2020"},{"issue":"5","key":"10.1016\/j.jiph.2021.03.004_bib0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4097\/kja.d.18.00242","article-title":"What is the proper way to apply the multiple comparison test?","volume":"71","author":"Lee","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.jiph.2021.03.004_bib0150","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","author":"Stuart","year":"2011","journal-title":"J Stat Softw"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Comput"},{"key":"10.1016\/j.jiph.2021.03.004_bib0160","series-title":"WeightIt: weighting for covariate balance in observational studies","author":"Greifer","year":"2020"},{"issue":"13","key":"10.1016\/j.jiph.2021.03.004_bib0165","first-page":"1","article-title":"Ipw: an R package for inverse probability weighting","volume":"43","author":"van der Wal","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jiph.2021.03.004_bib0170","doi-asserted-by":"crossref","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2021.03.004_bib0175","doi-asserted-by":"crossref","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis","author":"Zhang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jiph.2021.03.004_bib0180","doi-asserted-by":"crossref","first-page":"105053","DOI":"10.1016\/j.phrs.2020.105053","article-title":"Mortality in COVID-19 patients treated with ACEIs\/ARBs: re-estimated meta-analysis results following the Mehra et al. Retraction","volume":"160","author":"Alamer","year":"2020","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.jiph.2021.03.004_bib0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.hjh.0000160198.05416.72","article-title":"Why blockade of the renin--angiotensin system reduces the incidence of new-onset diabetes","volume":"23","author":"Jandeleit-Dahm","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jiph.2021.03.004_bib0190","series-title":"Unique variants in gene ACE2","author":"Global Variome shared LOVD","year":"2008"},{"issue":"8","key":"10.1016\/j.jiph.2021.03.004_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221248","article-title":"The combination of ACE I\/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: a genetic association study in Brazilian patients","volume":"14","author":"Pinheiro","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jiph.2021.03.004_bib0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ajh\/7.8.759","article-title":"Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension","volume":"7","author":"Duru","year":"1994","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.jiph.2021.03.004_bib0205","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1177\/1470320314549221","article-title":"The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients","volume":"16","author":"Yang","year":"2015","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0210","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2362.2007.01813.x","article-title":"Angiotensin-converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan","volume":"37","author":"Tseng","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jiph.2021.03.004_bib0215","first-page":"1","article-title":"Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19","author":"Khan","year":"2020","journal-title":"Drugs Ther Perspect"},{"issue":"9","key":"10.1016\/j.jiph.2021.03.004_bib0220","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1515\/cclm-2020-0727","article-title":"Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jiph.2021.03.004_bib0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jiph.2021.03.004_bib0230","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jiph.2021.03.004_bib0235","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","article-title":"COVID-19 with different severities: a multicenter study of clinical features","volume":"201","author":"Feng","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0240","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin\u2010converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID\u201019 infection in a multi\u2010site UK acute hospital trust","volume":"22","author":"Bean","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jiph.2021.03.004_bib0245","article-title":"Covid-19 testing, hospital admission, and intensive care among 2,026,227 united states veterans aged 54\u201375 years","author":"Rentsch","year":"2020","journal-title":"MedRxiv"},{"issue":"19","key":"10.1016\/j.jiph.2021.03.004_bib0250","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.jiph.2021.03.004_bib0255","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/10641963.2020.1783549","article-title":"Is the use of ACE inb\/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?","volume":"42","author":"Sel\u00e7uk","year":"2020","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"10.1016\/j.jiph.2021.03.004_bib0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.jiph.2021.03.004_bib0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of ARBs and ACEIs on virus infection, inflammatory status and clinical outcomes in COVID-19 patients with hypertension: a single center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jiph.2021.03.004_bib0270","doi-asserted-by":"crossref","first-page":"430","DOI":"10.21037\/atm.2020.03.229","article-title":"The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jiph.2021.03.004_bib0275","article-title":"Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients","author":"Liu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jiph.2021.03.004_bib0280","article-title":"Guidance from the CCS COVID-19 rapid response team","author":"Krahn","year":"2020","journal-title":"Can Cardiovasc Soc"},{"issue":"6","key":"10.1016\/j.jiph.2021.03.004_bib0285","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0735-1097(93)90578-O","article-title":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: a double-blind, placebo-controlled study of quinapril","volume":"22","author":"Pflugfelder","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jiph.2021.03.004_bib0290","series-title":"Elimination or prolongation of ACE inhibitors and ARB in coronavirus disease 2019 (REPLACECOVID)","author":"Clinicaltrial.gov","year":"2020"},{"key":"10.1016\/j.jiph.2021.03.004_bib0295","author":"Clinicaltrial.gov"},{"key":"10.1016\/j.jiph.2021.03.004_bib0300","series-title":"Stopping ACE-inhibitors in COVID-19 (ACEI-COVID)","author":"Clinicaltrial.gov","year":"2020"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:09:51Z","timestamp":1761750591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034121000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1876034121000691"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2021.03.004","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity of COVID-19 infection in ACEI\/ARB users in specialty hospitals: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}